A new approach for evaluating bone turnover in chronic kidney disease

European Journal of Internal Medicine

Volumn 21, Issue 3, 2010, Pages 230-232

  Tolouian, Ramin ^a   Hernandez, German T ^a   Chiang, Wen Yuan ^b   Gupta, Ajay ^c  

^a Paul L Foster School of Medicine   (United States)

^b Chander Medical Associates Inc   (United States)

^c Rockwell Medical   (United States)

Author keywords

Bone marker; Chronic kidney disease; NTx; Parathyroid hormone; Renal osteodystrophy

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; AMINO TERMINAL TELOPEPTIDE X; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHORUS; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; OUTPATIENT; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RACE; RENAL OSTEODYSTROPHY; SEX DIFFERENCE;

AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REMODELING; CHEMISTRY, CLINICAL; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PARATHYROID HORMONE; PEPTIDES; RENAL INSUFFICIENCY, CHRONIC; RENAL OSTEODYSTROPHY; REPRODUCIBILITY OF RESULTS;

EID: 77952290019     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.01.013     Document Type: Article

References (19)

1. Hruska K.A., and Teitelbaum S.L. Renal osteodystrophy. N Engl J Med 333 (1995) 166-174
2. Sherrard D.J., Hercz G., Pei Y., and Segre G. The aplastic form of renal osteodystrophy. Nephrol Dial Transplant 11 Suppl 3 (1996) 29-31
3. Hruska K. New concepts in renal osteodystrophy. Nephrol Dial Transplant 13 (1998) 2755-2760
4. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (2003) S1-S201
5. Sawaya B.P., Butros R., Naqvi S., Geng Z., Mawad H., Friedler R., et al. Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int 64 (2003) 737-742
6. Gupta A., Kallenbach L.R., Zasuwa G., and Divine G.W. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 11 (2000) 330-334
7. Sherrard D.J., Hercz G., Pei Y., Maloney N.A., Greenwood C., Manuel A., et al. The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43 (1993) 436-442
8. Salusky I.B., Ramirez J.A., Oppenheim W., Gales B., Segre G.V., and Goodman W.G. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45 (1994) 253-258
9. Goodman W.G. Recent developments in the management of secondary hyperparathyroidism. Kidney Int 59 (2001) 1187-1201
10. Goodman W.G., Ramirez J.A., Belin T.R., Chon Y., Gales B., Segre G.V., et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46 (1994) 1160-1166
11. Goodman W.G. Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis. Sem Dial 20 (2007) 1-4
12. Xue Y., Jia W., Zhang H., Dong J., Clemens J.D., and Tian X. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases. Chin Med J (Engl) 112 (1999) 149-152
13. Seibel M.J., and Woitge H.W. Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. J Clin Densitom 2 (1999) 299-321
14. Woitge H.W., Pecherstorfer M., Li Y., Keck A.V., Horn E., Ziegler R., et al. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res 14 (1999) 792-801
15. Coen G., Mantella D., Calabria S., Sardella D., Manni M., Fassino V., et al. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure. Am J Nephrol 20 (2000) 283-290
16. Ibrahim S., Mojiminiyi S., and Barron J.L. Pyridinium crosslinks in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 10 (1995) 2290-2294
17. Ibrahim S., Mojiminiyi S., and Barron J.L. High-performance liquid chromatographic determination of pyridinium crosslinks in serum, urine and dialysate of patients in chronic renal failure. Ann Clin Biochem 33 Pt 1 (1996) 31-35
18. Gupta A., Kallenbach L., and Divine G. Abstract. J Bone Min Res 12 Suppl (1997) S274
19. Kim S.W., Park D.J., Park K.S., Kim S.Y., Cho B.Y., Lee H.K., et al. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis. Endocr J 52 (2005) 667-674